Lipoprotein(a) Hormone Replacement Therapy and Risk of Future Cardiovascular Events

摘要

ObjectiveThis study assesses whether the relationship of lipoprotein(a) (Lp(a)) with cardiovascular risk may be modified by concurrent hormone therapy (HT).